Treatment of women urinary incontinence by artificial urinary sphincter: Efficacy, complications and survival

Objective. - To analyze long-term results and mechanical survival of the artificial urinary sphincter (AUS) AMS 800 (TM) (American Medical Systems, Minnetonka, MN, USA) in women with stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD). Patients and methods. - Data were collected prospectively from women treated for SUI at one university hospital between 1987 and 2007. Inclusion criteria was SUI with severe ISD defined by low urodynamic closure pressure and negative continence tests. Endpoints were survival, complications and continence. Results. - A total of 376 AUS were implanted in 344 patients with a median age of 57 years (18-93 years). The median follow-up was 9 years (3-20 years). The 3, 5, and 10 years global device survival were 92, 88.6, and 69.2% respectively. The mean mechanical survival was 176 months (14.7 years). The two main risk factors for decreased AUS survival were the number of previous incontinence surgeries and the presence of neurogenic bladder. The continence rates assessed as full (no leakage) in 85.64% patients, social (some drops but no pad) in 8.78% and incontinence (1 pad or more) in 5.58%. Conclusions. - The study has shown that in patients with ISD, the AUS represents an effective process, durable with an acceptable rate of complication. (C) 2012 Elsevier Masson SAS. All rights reserved.